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Decellularization and Characterization
of Porcine Superflexor Tendon:
A Potential Anterior Cruciate Ligament Replacement
Gemma Jones, PhD,1 Anthony Herbert, PhD,2 Helen Berry, PhD,3 Jennifer Helen Edwards, PhD,1
John Fisher, PhD,2 and Eileen Ingham, PhD1
The porcine superflexor tendon (SFT) was identified as having appropriate structure and properties for development
of a decellularized device for use in anterior cruciate ligament reconstruction. SFTs were decellularized using a
combination of freeze–thaw and washes in hypotonic buffer and 0.1% (w/v) sodium dodecyl sulfate in hypotonic
buffer plus proteinase inhibitors, followed by nuclease treatment and sterilization using peracetic acid. The decel-
lularized biological scaffoldwas devoid of cells and cell remnants and contained only 13 ng/mg (dryweight) residual
total DNA. Immunohistochemistry showed retention of collagen type I and III and tenascin-C. Quantitative analysis
of sulfated sugar and hydroxyproline content revealed a loss of glycosaminoglycans comparedwith native tissue, but
no loss of collagen. The decellularized SFTwas biocompatible in vitro and in vivo following implantation in amouse
subcutaneous model for 12 weeks. Uniaxial tensile testing to failure indicated that the gross material properties of
decellularized SFTs were not significantly different to native tissue. Decellularized SFTs had an ultimate tensile
strength of 61.8– 10.3MPa (–95% confidence limits), a failure strain of 0.29– 0.04, and a Young’s modulus of the
collagen phase of 294.1– 61.9MPa. Analysis of the presence of the a-Gal (galactose-a-1,3-galactose) epitope by
immunohistochemistry, lectin binding, and antibody absorption assay indicated that the epitopewas reduced, but still
present post decellularization. This is discussed in light of the potential role of noncellulara-Gal in the acceleration of
wound healing and tissue regeneration in the presence of antibodies to a-Gal.
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Introduction
The anterior cruciate ligament (ACL) is the mainintra-articular ligament in the knee joint1 and the most
commonly injured, with a reported 50,000–175,000 recon-
structions taking place each year in the United States.2
Rupture or tearing of the ACL leads to instability of the knee
and reduced function, which (if not treated effectively) can
lead to degenerative joint disease.3 The ACL has limited
vascular supply and capacity to heal and therefore if it is
ruptured or torn, the only viable treatment is surgical recon-
struction. The current gold standard for ACL reconstruction is
autologous bone–patellar tendon–bone; however, the use of
semitendinosus or gracilis tendon has become more popular
in recent years.4,5 Autografts offer good results and the ad-
vantage of no disease transmission or adverse immune re-
sponse6,7; however, limitations include donor site morbidity,
increased operative time, and the potential for the harvested
tissue to prove unsuitable. The major alternative is to use
tendon allograft with advantages of shorter less complicated
surgeries, no donor site morbidity, and the availability of
larger grafts.8,9 The major disadvantage of ACL reconstruc-
tion using allograft is that the donor tissue may suffer an
adverse immune response. Reconstruction of the ACL using
allograft tissue has also been shown to have a higher failure
rate in younger more active patients.6
Following ACL reconstruction surgery with autografts or
allografts, the endogenous cells are unlikely to survive,
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leading to initial graft deterioration.10 During the remodel-
ing process, there is a marked decrease in biomechanical
strength of tendon autografts, which can be attributed to
initial cell necrosis within the tissue.10 Following implan-
tation, the rate of tissue degradation is greater than host cell
repopulation.11,12 Indeed, it may well be better to use a non-
vital graft with a stable matrix, such as an acellular natural
tendon scaffold.
Biological scaffolds produced by decellularization of
mammalian tissues are used extensively in surgical appli-
cations. Mostly derived from porcine small intestinal sub-
mucosa, human or animal dermis, or pericardium, their use
is typically limited by inadequate biomechanical proper-
ties.13 The innovation in our approach has been to develop
processes for decellularization of the tissue type to be re-
placed, preserving the physical properties, thus delivering
the natural multiscale hierarchical matrix architecture for
appropriate tissue-specific biomechanical and biological
functions. We have produced tissue-specific acellular biological
scaffolds for use in cardiovascular,14 musculoskeletal,15,16 and
wound care17 applications. In this study, we describe the
decellularization and characterization of porcine superflexor
tendon (SFT), which was identified as having appropriate
structure and biomechanical properties for potential use in
ACL reconstruction.
Materials and Methods
Tissue procurement
The hind legs of female, 70 kg, 4-month-old, large White
pigs were obtained from an abattoir ( J. Penny, Leeds) within
24 h of slaughter. The SFT is located in the porcine foot
running from the toe to the ankle. The SFT was identified
after removal of the skin and subcutaneous tissue and
cleaned of connective tissue before being aseptically dis-
sected. The porcine SFT divides into two bands approxi-
mately halfway along its length and one band was carefully
removed, taking care not to damage the remaining tissue.
The SFTs were stored at -80C on filter paper moistened
with phosphate-buffered saline (PBS; Oxoid) until required.
Decellularization of porcine SFTs
SFTs were decellularized in batches of 12. SFTs were
subjected to three freeze–thaw cycles at -80C. The first
freeze–thaw was conducted on dry tissue. SFTs were then
immersed in hypotonic buffer plus proteinase inhibitors
(10mM Tris [Sigma Aldrich]; 2.7mM disodium ethylene-
diamine-tetra acetic acid [EDTA; Thermo Fisher Scientific];
10KIU/mL aprotinin [Nordic Pharma], pH 8.0), and frozen
and thawed at room temperature (RT, 22–25C) twice. SFTs
were washed in acetone (WVR International) three times for
1 h (RT) to remove fat, then washed five times in PBS plus
aprotinin (10KIU/mL) to remove the acetone at RT. All
subsequent steps in the process were conducted on tendons
in individual pots containing 100mL of solution at 37C
with agitation, unless otherwise stated. Tendons were dis-
infected in a solution of 0.5mg/mL gentamicin sulfate
(VWR International), 0.05mg/mL vancomycin hydrochlo-
ride (Sigma), and 0.2mg/mL polymyxin B (Sigma) in PBS
for 1 h. Tendons were washed in hypotonic buffer for 24 h
and then hypotonic buffer plus 0.1% (w/v) sodium dodecyl
sulfate (SDS; Sigma) for 24 h. The washes in hypotonic
buffer and hypotonic buffer plus SDS were repeated twice.
SFTs were washed in PBS plus aprotinin three times for
30min, 70 h, and 30min before treatment with nuclease
(1U/mL benzonase [Merk] in 60mL 50mM Tris plus 1mM
MgCl2 [Thermo Fisher Scientific] at pH 7.6) for 2 h, three
times. SFTs were washed three times in PBS plus 2.7mM
EDTA before an 18-h wash in hypertonic buffer (50mM
Tris; 1.5M NaCl [Sigma]; pH 7.6). After three 30-min PBS
washes, SFTs were sterilized using peracetic acid (0.1% v/v,
pH 6; Sigma) for 3 h. Finally the SFTs were washed in PBS
three times for 30min, twice for 60 h, and once for 120 h and
stored refrigerated in PBS.
Histology and immunohistochemistry
Six decellularized SFTs were analyzed and compared
with native tissue (n = 6). Transverse and longitudinal
samples were taken from the toe insertion point (toe region),
middle, and ankle insertion point (ankle region) of each
tendon and fixed in 10% (v/v) neutral buffered formalin
(NBF; Genta Medical) for histochemical staining and zinc
fixative (0.1M tris; 3.2mM calcium acetate [Thermo Fisher
scientific], 27mM zinc acetate [Sigma Aldrich], and 37mM
zinc chloride [Fluka] pH 7.2) for 4 days for immunohisto-
chemical analysis. The samples were processed automati-
cally (Leica 11020 Tissue processor) and embedded in
paraffin wax using standard techniques. For histochemical
staining, sections (6 and 10 mm) were taken from the surface
through to the central region of each block and stained with
hematoxylin (Biostain ready reagent) and eosin (Merck)
(H&E), 4¢,6-diamidino-2-phenylindole (DAPI; Sigma), Al-
cian blue (Atom Scientific), and Sirius red (WVR Interna-
tional)/Millers elastin stains (Raymond A Lamb).
For immunohistochemistry, sections were taken at 6 mm.
The Ultra Vision system-HRP kit (Thermo Scientific) was
used for antibody detection. Sections were analyzed using
monocloncal antibodies to collagen I, collagen II, collagen
III (all at 1:50 dilution; Chemicon), and tenascin-C (1:100;
Leica Microsystems) and polyclonal antibodies to galactose-
a-1,3-galactose (a-Gal; 0.37mg/mL; Enzo Life Sciences).
Omission of the primary antibody and isotype control anti-
bodies (mouse IgG1; rabbit IgM) were used as controls.
Sections of native and decellularized SFTs were also treated
with a-galactosidase for 20–24 h at 37C (5U/mL; Sigma)
to remove the a-Gal epitope from the tissue as an additional
negative control for determination of a-Gal. Sections were
blocked with dual endogenous enzyme block (Ultra Vision).
Antibodies were diluted in Tris-buffered saline (TBS) con-
taining 0.1% (w/v) bovine serum albumin (Sigma). The
sections were incubated with the diluted antibodies, isotype
controls, or antibody diluent only for 1 h, TBS and TBS
containing 0.05% (v/v) Tween (Sigma) were used as wash
buffers throughout. The sections were labeled with polymer
horseradish peroxidase (HRP), followed by DAB chroma-
gen from the Ultra Vision kit.
The presence of the a-Gal epitope in tissue sections was
also analyzed using biotinylated GSL-1 lectin (Vector
Labs). Sections were blocked with streptavidin/biotin and
carbo-free blocking solution (Vector Labs). Lectin was used
at 5mg/mL in TBS. The streptavidin polymer and IMMpact
DAB chromagen (Vector Labs) were used to visualize lectin
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binding. Lectin (5mg/mL) absorbed with 200mM galac-
tose, omission of the lectin, and a-galactosidase-treated
sections were used as negative controls. All sections were
viewed using an Olympus BX51 microscope and imaged
using an Olympus XC50 digital camera controlled through
Cell B software (Olympus, United Kingdom).
Determination of total DNA content of native
and decellularized SFTs
The total DNA content of six decellularized SFTs was de-
termined and compared with the DNA content of native tissue.
Tissue samples were taken from the toe, middle, and ankle
regions of each tendon, combined, and macerated using a
scalpel blade. The samples were weighed (circa 25mg fresh
tissue and 250mg decellularized tissue) and freeze-dried to a
constant weight. The DNA was extracted using a DNeasy
blood and tissue kit (Qiagen) following the manufacturer’s
instructions. The extracted DNAwas then quantified at 260 nm
using a nanodrop spectrophotometer (ND-500 Labtech).
Determination of collagen content
of decellularized SFTs
The total collagen content of native (n = 6) and decel-
lularized (n = 6) SFTs was determined using the hydro-
xyproline assay. Samples of native and decellularized
tendons were freeze-dried to a constant weight, hydrolyzed
in 6M HCl for 4 h at 120C, and neutralized with 6M
NaOH. Test samples (50mL) were added to 96-well plates
with 100mL of chloramine-T solution (chloramine-T hy-
drate; Sigma) for 5min with agitation. Ehrlich’s reagent
(100 mL; Sigma) was added to each well and the wells
covered and incubated at 60C for 45min. The absorbance
was read at 570 nm. The hydroxyproline content of test
samples was determined by interpolation from a standard
curve of trans-4-hydroxy-l-proline (Sigma).
Determination of the glycosaminoglycan content
of decellularized SFTs
The glycosaminoglycan (GAG) content of native (n= 6)
and decellularized (n = 6) SFTs was determined using the
dimethylene blue assay. Native and decellularized tendon
samples were freeze-dried to a constant weight before being
digested in papain (1250 units [Sigma] in 25mL of 5mM l-
cysteine hydrochloride plus 5mM Na2EDTA [WVR Inter-
national]) for 26 h at 60C with agitation. Standard or test
solutions (40mL) were added to wells of 96-well plates with
250 mL 1,9-dimethylene blue solution (DMB). Absorbance
was read at 525 nm after 2min of incubation. The sulfated
sugar content of the test samples was determined by inter-
polation from the standard curve of chondroitin sulfate B
(mg/mL; Sigma) versus OD 525 nm.
Semiquantitative analysis of a-Gal content
of decellularized SFT
Tissue samples (100mg) from five different native and
decellularized SFTs were macerated and added to individual
1.5-mL microcentrifuge tubes. a-Galactosidase (5U/mL in
50mM Tris pH 6.0) was added to the samples of native and
decellularized tissue and rotated at 37C for 24h (negative
control tissue). Native, decellularized, and negative control
tissues were placed into individual tubes and purified mono-
clonal antibody to a-Gal diluted to 0.37mg/mL in TBS was
added to all samples. Antibody only (no tissue) was included
as a no tissue control. The mixtures were rotated at 4C for
16h. Following incubation, the samples were centrifuged at
600 g for 15min and the supernatant (100mL)was added to the
wells of MaxiSorp plates (Nunc) that had been coated with
50mL a-Gal-BSA (10mg/mL in PBS; Dextra) overnight at 4C
and incubated for 3 h at RT. Following this, 50mL secondary
rabbit anti-mouse HRP antibody (1:1000; Dako) was added to
the wells and incubated for 1 h at RT. The plates were washed
with TBS before adding 100mL o-phenylenediamine dihy-
drochloride (OPD) solution (Sigma) and incubating for 10min
at RT in the dark. The reaction was stopped with 50mL 3M
sulfuric acid and the absorbance measured at 490 nm with a
reference filter of 630 nm.
Determination of the biocompatibility
of decellularized SFT tissue
The in vitro biocompatibility of decellularized SFTs
(n= 6) was determined using contact and extract biocom-
patibility assays.
Cell culture. Murine 3T3 fibroblastic cells (European
Collection of Cell Cultures; ECCAC) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) plus 10%
(v/v) fetal calf serum (FCS), 2mM l-glutamine, and 100U/
mL penicillin/streptomycin (all from Lonza). Baby hamster
kidney (BHK; ECCAC) cells were cultured in Glasgow‘s
minimum essential medium plus 5% (v/v) FCS, 10% (v/v)
tryptose phosphate broth (29.5 g/L; Sigma), and 100U/mL
penicillin/streptomycin. The cells were cultured at 37C in
5% (v/v) CO2 in air in a humidified atmosphere.
Contact biocompatibility assay. Samples from the toe,
middle, and ankle regions of decellularized SFTs were at-
tached to the center of wells of a six-well plate (Nunc) using
Steri-Strips (3M; Medisave). Cyanoacrylate (RS Systems)
was used as the positive control and Steri-Strip alone as the
negative control. BHK and 3T3 cells were seeded at 5 · 105
cells in 2mL of appropriate culture medium into the sample
and control wells and cultured for 48 h at 37C in 5% (v/v)
CO2 in air in a humidified atmosphere. The cell monolayers
were washed with PBS, fixed with 10% (v/v) NBF, and
stained with Giemsa solution (WVR International) before
being washed with tap water and allowed to dry. The plates
were then imaged by light microscopy.
Extract cytotoxicity assay. Samples from each region of
the decellularized SFTs (toe, middle, and ankle) were
macerated and incubated in DMEM (300mg tissue in 3mL
DMEM) for 72 h at 37C with agitation. BHK (1· 105) or
3T3 (2.5 · 105) cells in 200mL of appropriate culture me-
dium were seeded into the wells of 96-well plates (Nunc)
and cultured for 24 h at 37C in 5% (v/v) CO2 in air. The
culture medium was aspirated from the wells and 100mL of
the tissue extract plus 100 mL of appropriate culture medium
(with double strength supplements) was added. The positive
control was 40% (v/v) dimethyl sulfoxide (DMSO; Sigma)
in culture medium (200 mL) and cells cultured in medium
alone served as negative controls for cytotoxicity. The cells
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were cultured for 48 h before assessing cell viability by
measuring cellular ATP. ATP was measured using the
ATPLite assay kit (PerkinElmer) following the manufac-
turer’s instructions. The luminescence (counts per second)
in each well was measured using a TopCount (C9902 Perkin
Elmer) luminescence plate reader.
In vivo biocompatibility of decellularized SFT tissue
The host response to fresh (n = 3) and decellularized
(n = 6) SFTs was assessed in a mouse subcutaneous implant
model. Female C3H mice, 6–12 weeks old (Harlan), were
anesthetized, the mid-dorsum of the mice was shaved and
aseptically prepared and a small incision was made in the
dorsal skin. Tissue samples (3mm3) taken from the central
region of the midportion of each tendon were implanted
subcutaneously along the mid-dorsal line distant from the
skin incision. Mice were fed food and water ad libitum and
left for a period of 3 months. Mice were sacrificed according
to schedule (1) and the sample and surrounding skin har-
vested for analysis. All animal procedures were carried out
in accordance with UK Home Office regulations and with
appropriate Home Office licenses.
The explanted samples were fixed in NBF for 48 h before
being processed and embedded in paraffin wax. Sections
were taken at 6 mm, retaining one section in every 200
throughout the full thickness of the tissues. Sections were
stained with H&E and viewed as described above.
Tensile testing of native and decellularized SFTs
Six native and acellular SFTs were snap-frozen by im-
mersion in dry ice and processed into dumbbell shapes of
consistent cross-sectional area of 3.5 · 5mm and gauge
length of 30mm. Specimens were then wrapped in PBS-
soaked paper and allowed to thaw and equilibrate at RT for
at least 2 h before biomechanical tensile testing.
Specimens were mounted through bespoke cryogrips to
an Instron 3366 (Instron, Bucks, United Kingdom) material
testing machine equipped with a 1 kN load cell. The grips
were manufactured with a void into which dry ice was
placed to reduce the primary gripping surface to subzero
temperatures. Once secured in the cryogrips, specimens
were tensioned to a preload of 0.5N to ensure tautness was
achieved. This load was subsequently tared and tensile
testing performed. This consisted of 10· preconditioning
cycles between 0% and 5% strain at a rate of 15mm/min,
followed by an extension ramp to failure at a rate of 30mm/
min. Load and extension data were recorded at a frequency
of 10Hz, from which the ultimate tensile strength (UTS),
failure strain (eFAIL), and Young’s modulus of the collagen
phase (ECOLL) of the specimens were calculated.
Analysis of data
Statistical analysis was performed using Student’s t-test
(native vs. acellular tissue) or one-way analysis of variance
(ANOVA), followed by the T-test, to determine minimum
significant differences (MSD) between more than two group
means. A p-value of less than 0.05was deemed to be significant.
Results
Gross structure of the porcine SFT
The SFTs harvested from pigs (n = 6) had a length of
19.7 – 1.1 cm (–95% confidence limits [CL]), a width of
11.2 – 1.3mm, and a depth of 3.9 – 0.28mm. Images of the
porcine SFT before and after decellularization are shown in
Figure 1.
Histological and immunohistochemical analysis
of native and decellularized SFT
Sections of native tendons stained with H&E and DAPI
(Fig. 2A, C) revealed the presence of cells neatly aligned
along the crimp of the collagenous tissue matrix. Blood
vessels were apparent in the endotenon regions where there
were large aggregations of cells. Sections stained with Sirius
red/Millers viewed under polarized light (Fig. 2E) showed the
aligned collagen fibers and also demonstrated the crimp for-
mation of the fibers. Under bright-field illumination, Millers
stain did not reveal the presence of any elastin in the tissue
sections when the stain was combined with Sirius red. Millers
staining alone showed that there was elastin present in the
endotenon regions surrounding blood vessels. Alcian blue-
stained tissue sections (Fig. 2G) showed GAGs distributed
throughout the tissue; however, the GAGs were more con-
centrated around the vascularized endotenon regions.
Sections of decellularized tendons stained with H&E
(Fig. 2B) and DAPI (Fig. 2D) revealed the absence of any
cell nuclei or double-stranded DNA. The histoarchitecture
of the matrix appeared similar to native tissue with evidence
of some loss of collagen fiber crimp. Sections stained with
Sirius red/Millers (Fig. 2F) demonstrated the retention of the
tendon collagen fiber alignment. Alcian blue-stained sections
(Fig. 2H) showed a decrease in the GAG content throughout
the decellularized tissue compared with the native tissue.
Scanned images of the decellularized porcine SFT stained with
FIG. 1. Image of the porcine su-
perflexor tendon (SFT) before (top)
and after (bottom) decellularization.
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H&E are provided in Supplementary Figure S1 (Supplemen-
tary Data are available online at www.liebertpub.com/tea).
Native tendon, positive control tissues, and isotype con-
trols allowed verification of the specificity of antibodies
used for detection of collagens I, II, III, and tenascin-C. The
native tendon sections stained strongly for both collagens I
(Fig. 3A) and III (Fig. 3C) throughout the tissue. Tenascin-C
stained positively mainly around the endotenon regions
(Fig. 3E). There was no positive staining for collagen II.
Sections of decellularized SFT showed similar patterns of
staining, with no apparent difference in collagen I (Fig. 3B),
collagen III (Fig. 3D), or tenascin-C (Fig. 3F) staining.
Labeling of the a-Gal epitope in the tissue sections using
both GSL-1 lectin and monoclonal antibody to the a-Gal
epitope showed very strong staining in the endotenon re-
gions of the native tendon. Sections of the decellularized
tissue also showed positive staining with both the mono-
clonal antibody to a-Gal and the GSL-1 lectin, although this
was reduced compared with native tissues. Controls of a-
galactosidase-treated tissue sections and use of GSL-lectin
absorbed with galactose confirmed the specificity of lectin to
a-Gal. Images of sections stained with the GSL-1 lectin and
controls are shown in Figure 4. This indicated that a-Gal
was still present in the tissue following decellularization.
FIG. 2. Images of histological
sections of native (A, C, E, G) and
decellularized (B, D, F, H) porcine
SFTs. Stained with hematoxylin
and eosin (H&E; A, B) showing an
absence of cells postdecellulariza-
tion. Stained with 4¢,6-diamidino-
2-phenylindole (DAPI) showing
the blue-stained nuclei in (C), but
not (D). Stained with Sirius red/
Millers (E, F) and captured under
polarized light showing the
crimped nature of the collagenous
matrix. Stained with Alcian blue
(G, H) with blue-stained glycos-
aminoglycans (GAGs) mainly in
the endotenon (G), but less preva-
lent in (H). All images captured at
10· magnification. Scale bars
200 mm.
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Total DNA content of native and decellularized SFTs
Native porcine SFT had a mean total DNA content of
303 ng/mg per tissue dry weight. Following decellulariza-
tion, the mean total DNA content of the tissue was 13 – 4.2
(95% CL) ng/mg per tissue dry weight tissue ( p< 0.0001;
Student’s t-test).
In vitro biocompatibility of decellularized SFT
Contact cytotoxicity assays. BHK and 3T3 cells grew up
to and in contact with the decellularized tissue isolated from
all regions (toe, middle, and ankle) of the tendon (represen-
tative images in Fig. 5). The cells did not show any change in
morphology compared with the cells cultured alone or with
Steri-Strip (negative controls). Cyanoacrylate glue (positive
control) was highly toxic to the cells, resulting in cell lysis.
Extract cytotoxicity assays. Murine 3T3 cells cultured
with tissue extracts from each of the six tendons showed no
significant differences in ATP levels compared with the
negative control (cells grown in culture medium; Fig. 5).
The BHK cells cultured with the majority of tissue extracts
did not show any significant difference in ATP levels
compared with the negative control; however, there was a
small but significant decrease in ATP levels in BHK cell
culture in the presence of 4/18 extracts (Fig. 6).
Collagen and GAG content of native
and decellularized SFTs
Native SFT had a hydroxyproline content of 138– 21mg/mg
(mean [n= 6]– 95% CL) of dry weight, indicating that the
extracellular matrix of the SFT mainly comprised collagen.
Following decellularization, the SFT had a mean hydro-
xyproline content of 163– 21mg/mg, which was not signifi-
cantly different to the native tissue (Student’s t-test). The total
sulfated sugar content of the native SFT was very low at
6.85– 1.7mg/mg (mean [n= 6]– 95% CL). Following decel-
lularization, the total sulfated sugar content was reduced sig-
nificantly to 1.79– 1.48mg/mg ( p< 0.001; Student’s t-test).
Semiquantitative determination of the a-Gal epitope
in native and decellularized SFTs
Following adsorption of antibody to a-Gal present in
samples of native, decellularized, and a-galactosidase-
treated tissues, the relative levels of nonadsorbed antibody
were determined by ELISA using a-Gal-BSA (Fig. 7). There
was no significant difference in the amount of anti-a-Gal
FIG. 3. Images of sections of
native (A, C, E) and decellularized
(B, D, F) porcine SFTs stained with
antibodies to collagen 1 (A, B),
collagen III (C, D), and tenascin-C
(E, F). The images show retention
of the major structural proteins and
the glycoprotein, tenascin-C, post-
decellularization. All images cap-
tured at 10· magnification. Scales
bars 200 mm.
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antibody in the supernatant from the no tissue control and
the a-galactosidase-treated native and decellularized tissues,
indicating that a-galactosidase treatment effectively re-
moved the a-Gal epitope from the tissues. The antibody
levels in the supernatants from the native and decellularized
tissues were significantly ( p < 0.05; ANOVA) lower than the
no tissue control and the a-galactosidase-treated native and
decellularized tissues (indicated by the lower absorption
values). The decellularized SFT tissue absorbed fewer an-
tibodies than the native SFT tissue, indicating that the de-
cellularization process had removed some a-Gal; however,
the difference was not significant.
FIG. 4. Lectin binding in sections of native and decellularized porcine SFTs. (A) Native SFT stained with GSL-1 lectin,
showing positive binding of lectin mainly in the endotenon regions; (B) native SFT treated with a-galactosidase to remove
a-Gal and stained with GSL-1 lectin, showing an absence of binding of lectin following the enzyme treatment; (C) native
SFT stained with GSL-1 lectin that had been absorbed with galactose, showing an absence of binding of lectin, indicating
the specificity of lectin to galactose moieties in the tissue; (D) decellularized SFT stained with GSL-1 lectin, showing reduced,
but positive, binding of lectin mainly in the endotenon regions; (E) decellularized SFT stained with GSL-1 lectin that had been
absorbed with galactose, showing an absence of binding of lectin indicating the specificity of the lectin to galactose moieties in the
decellularized tissue; and (F) decellularized SFT nonlectin control treatedwith streptavidin polymer and chromagen only, showing
an absence of background staining due to lectin detection reagents.
FIG. 5. Images of contact cytotoxicity assays to determine the biocompatibility of decellularized porcine SFT. Top row:
baby hamster kidney (BHK) cells cultured in the presence of samples of decellularized SFT (A, B), Steri-Strip alone,
negative control (C), and cyanoacrylate, glue positive control (D). Bottom row: 3T3 cells cultured in the presence of
samples of decellularized SFT (E, F), Steri-Strip alone, negative control (G), and cyanoacrylate glue, positive control (H).
The cells have been stainedwithGiemsa. The images show that both cell types grew up to and in contact with the decellularized
SFT with no change in morphology compared with the negative control (Steri-Strip), while the positive control caused cell
lysis. Images captured at 10· magnification. Scale bars 200 mm.
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Biocompatibility of decellularized SFT in vivo
The native and decellularized tissue samples were ex-
planted from mice and analyzed by histology. Sections of
native tissue stained with H&E revealed a fibrous capsule
around the tissue with little evidence of cellular infiltration
into the depth of the tissue. Moreover, the native tissue ex-
plants were calcified and degenerating in the central regions
indicated by dark staining (Fig. 8A, B). Histological sections
of explanted decellularized SFT samples revealed minimal
capsule formation with evidence of cellular infiltration with
cells of a fibroblastic and macrophage morphology into the
depth of tissues and an absence of calcification (Fig. 8C, D).
Scanned images of the tissues explanted from mice at 12
weeks are provided in Supplementary Figure S2.
Material properties of native and decellularized SFTs
When subjected to uniaxial tensile testing to failure,
midsubstance failure of all native and decellularized tissues
was achieved. There were no significant differences in the
UTS, failure strain, or Young’s modulus of the collagen
phase of the native compared with decellularized tissue
specimens (Student’s t-tests; Table 1).
Discussion
The porcine SFT was chosen as the source tissue for the
development of a decellularized biological scaffold for ACL
replacement because it could be routinely harvested in di-
mensions that are currently used for ACL replacement using
hamstring tendon autografts. Grafts greater than 7mm in
diameter are preferred with a length of at least 9 cm for a
single-stranded graft or at least 18 cm for a double-bundle
graft18 and the porcine SFT met these specifications. The
aim of this study to develop and evaluate a bioprocess for
removal of immunogenic cells and cellular remnants from
the porcine SFT that has minimal effect on the extracellular
matrix and mechanical properties of the tissue was achieved.
The residual total DNA of the decellularized SFT was circa
13 ng/mg dry weight of tissue. This was well below the levels
of double-stranded DNA of 50ng/mg reported to be indica-
tive of a decellularized tissue that would undergo construc-
tive tissue remodeling in vivo.13,19,20 Immunohistochemical
analysis showed retention of structural collagens and tenascin-
C post decellularization. Tenascin-C is an extracellular matrix
glycoprotein found in all musculoskeletal tissues. It is impor-
tant in regulating cellular differentiation and proliferation and
is believed to have a role in the healing process following
musculoskeletal injury.21–23 Proteoglycans with associated
GAGs account for less than 1% of tendon dry weight.24 The
native SFTwas found to contain circa 0.7%GAGs, whichwere
located mainly in the endotenon regions. GAG depletion fol-
lowing decellularization was confirmed by quantitative analy-
sis. The reduction of GAG content was not unexpected since
previous studies have shown that decellularization of tissues
using SDS leads to a loss of GAGs.15,25
FIG. 6. ATP levels in 3T3 (A) and BHK (B) cells cultured
in the presence of extracts of decellularized SFT. Data are
presented as the mean (n= 3) counts per second· 10-6– 95%
confidence limits following ATP Lite assay of cells fol-
lowing 48h of culture in the presence of decellularized tissue
extracts. One to six indicate six different decellularized SFTs;
A (ankle), M (mid-tendon), and T (toe) region of the tissue
sample used to prepare the extract. Con represents cells
cultured in the absence of extract with culture medium alone
and dimethyl sulfoxide (DMSO) the positive control for
toxicity. Data for each cell line were analyzed by one-way
analysis of variance (ANOVA), followed by the T-test to
determine any significant differences between group means. *
Indicates significantly lower than the control (Con; p< 0.05).
FIG. 7. Semiquantitative evaluation of a-Gal in native and
decellularized SFTs. Absorption at 490–630 (reference) in
ELISA for detection of antibodies to a-Gal following ad-
sorption with native SFT (NSFT), native SFT treated with
a-galactosidase (aNSFT), decellularized SFT (DSFT), and
a-galactosidase-treated decellularized SFT (aDSFT). NTC
is the no tissue control (one group for each ELISA plate).
Data are presented as the means (n= 5)– 95% confidence
intervals. Data were analyzed by one-way ANOVA, followed
by determination of the minimum significant differences us-
ing the T-method. * Indicates significantly lower ( p< 0.05)
than the respective NTC and a-galactosidase-treated tissue.
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The a-Gal epitope is present on cell membrane glyco-
lipids and glycoproteins of lower mammals, but is not ex-
pressed in humans. Humans naturally produce antibodies,
which recognize the a-Gal epitope, and these antibodies
have a role to play in the hyperacute rejection of vascular-
ized whole-organ xenografts.26 It was therefore of interest to
determine the presence of the a-Gal epitope in the native
and decellularized SFTs. The a-Gal epitope was mainly
located in the endotenon regions of the native SFT, con-
sistent with reported localization to the basement mem-
brane.27 Qualitative and semiquantitative analysis of a-Gal
showed that although the levels of a-Gal were reduced in the
decellularized SFT compared with native porcine tissue, the
epitope was still present. Whether the presence of residual
a-Gal in acellular connective tissue biological scaffolds is of
concern or indeed an attribute for future clinical translation
requires discussion.
It has been well documented that acellular biological scaf-
folds derived from porcine tissues (such as the porcine intes-
tinal submucosa) that have been used clinically in millions of
patients stimulate a constructive remodeling response orches-
trated by macrophages that have a regenerative wound healing
phenotype (M2; macrophages; Brown et al.28). It is also rec-
ognized that these biological scaffolds retain the a-Gal epi-
tope.29 Recently, studies conducted in 1,3-galactosyltransferase
knockout (GTKO) mice (which lack the a-Gal epitope and can
produce anti a-Gal antibodies) have shown that application of
a-Gal liposomes onwounds accelerated healing comparedwith
control wounds by rapid recruitment and activation of macro-
phages.30 Moreover, scar formation was reduced. Similar
studies in GTKO pigs31 have led to the concept that anti-Gal/a-
Gal nanoparticles may have utility in tissue regeneration and
prevention of fibrosis.32,33 Hence, although the expression of a-
Gal by cells in xenogeneic organs and tissues may lead to
antibody-dependent complement activation, cell lysis, and a
proinflammatory response when transplanted in humans, the
presence of the a-Gal epitope in the absence of cells in decel-
lularized biological scaffolds may indeed contribute to rapid
recruitment of macrophages, which are polarized to the wound-
healing M2 phenotype, inducing tissue regeneration.
The decellularized SFT showed good biocompatibility in
in vitro assays. The decellularized SFT was therefore tested
for biocompatibility in a subcutaneous implant model in
mice in comparison with native porcine SFT. The native
FIG. 8. Images of sections of native and decellularized SFTs explanted from mice following 12 weeks of subcutaneous
implantation stained with H&E. (A) Native SFT showing capsule formation and calcification (dark stain) and degradation of
the central area of the implant; image captured at 4·magnification (scale bar 500mm); (B) native SFT at higher magnification
showing cellular infiltration around the periphery of the tissues, but calcification (dark stain) and degradation of the central area
of the implant; image captured at 10·magnification (scale bar 200mm); (C) decellularized SFT showing cellular infiltration of
the periphery of the tissue with a few cells penetrating the dense intact matrix; image captured at 4· magnification (scale bar
500mm); (D) higher power image of decellularized SFT showing cells aligningwith the tendon collagen fibers; image captured
at 20· magnification (scale bar 100mm).
Table 1. Material Properties of Native
and Decellularized Superflexor Tendons
UTS (MPa) eFAIL (mm/mm) ECOLL (MPa)
Native 52.5 – 5.9 0.33 – 0.05 234.2– 51.3
Acellular 61.8 – 10.3 0.29 – 0.04 294.1– 61.9
p 0.07 0.15 0.08
The material properties were determined by uniaxial tensile
testing. Data are presented as the means (n = 6)– 95% confidence
limits. The data for native and decellularized SFT samples were
compared by Student’s t-test, which showed no significant differ-
ences between the two groups.
UTS, ultimate tensile strength.
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tissue stimulated a foreign body-type response and the cel-
lular tissue was heavily calcified at the center and showed
signs of degeneration, most likely due to the presence of
dead cells within the tissue. In contrast, the decellularized
SFT tissue was well accepted in the mouse model with no
evidence of an overt inflammatory or specific immune re-
sponse; the tissue was not degenerated and calcified. Cells
of a fibroblastic and macrophage morphology were observed
penetrating the implanted decellularized tissue.
With regard to the potential of the decellularized porcine
SFT for future clinical translation as a device for ACL re-
construction, the biomechanical properties of the scaffold
are of utmost consideration. The UTS of the natural human
ACL has been reported to be circa 36MPa,34 while the
natural human patella tendon, which is the current graft of
choice for reconstruction, has a UTS of circa 68MPa.35 The
native porcine SFT was found to have a UTS of 52.5MPa
and, following decellularization, the UTS was not signifi-
cantly different (62MPa). Hence, the strength of the de-
cellularized porcine SFT is well within the range needed to
meet surgical requirements. The porcine SFT also has similar
dimensions to the human hamstring tendon, which is com-
monly used for ACL reconstruction.
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